| __timestamp | Apellis Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2908166 | 38783000000 |
| Thursday, January 1, 2015 | 6356782 | 42585000000 |
| Friday, January 1, 2016 | 4303743 | 45702000000 |
| Sunday, January 1, 2017 | 10463151 | 46372000000 |
| Monday, January 1, 2018 | 22639184 | 46910000000 |
| Tuesday, January 1, 2019 | 67046483 | 48890000000 |
| Wednesday, January 1, 2020 | 139401000 | 50129000000 |
| Friday, January 1, 2021 | 176771000 | 54559000000 |
| Saturday, January 1, 2022 | 277163000 | 62081000000 |
| Sunday, January 1, 2023 | 500815000 | 105931000000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining competitive advantage. Dr. Reddy's Laboratories Limited, a stalwart in the field, has consistently demonstrated robust cost management, with SG&A expenses peaking at approximately 106 billion in 2023, a 63% increase from 2014. In contrast, Apellis Pharmaceuticals, Inc., a relatively newer player, has seen a dramatic rise in SG&A expenses, skyrocketing from a modest 2.9 million in 2014 to over 500 million in 2023, marking an exponential growth of over 17,000%. This stark contrast highlights the differing strategies and growth trajectories of established versus emerging pharmaceutical companies. Notably, data for 2024 is incomplete, suggesting ongoing developments in this dynamic sector. Understanding these trends offers valuable insights into the financial strategies shaping the future of pharmaceuticals.
Amgen Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Xencor, Inc.: Who Manages SG&A Costs Better?
Ultragenyx Pharmaceutical Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Wave Life Sciences Ltd. Trends and Insights